Owner of peptide firm sentenced to nearly six years for fraud and illegal imports

U.S. District Judge Cristal Brisco sentenced Matthew Kawa, the 48-year-old owner of Paradigm Peptides, to 70 months in federal prison after he admitted to selling unapproved drugs and illegally importing them from overseas. The court also ordered Kawa to forfeit $5 million in proceeds. Federal prosecutors estimated the business reached more than 54,000 unique customers in all 50 states and 80 countries, falsely claiming American-made, 99% pure products that were actually imported and often contained testosterone despite being labeled as SARMs or research-grade peptides.

Kawa’s sister, Jennifer Stechkober, was given a 16-month term for her involvement, though the judge noted she was not the mastermind. The sentencing is a rare criminal penalty in the “research-use-only” peptide market, which has attracted users seeking weight loss, muscle gain, or anti-aging benefits. Experts say the case may serve as a warning to other vendors operating in this gray area. One former customer described severe side effects, including insomnia, acne, and paranoid thoughts, after using the company's SARMs, underscoring the health risks of unregulated products.